» Articles » PMID: 19000920

The Thyrotropin-releasing Hormone (TRH)-immune System Homeostatic Hypothesis

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2008 Nov 13
PMID 19000920
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Decades of research have established that the biological functions of thyrotropin-releasing hormone (TRH) extend far beyond its role as a regulator of the hypothalamic-pituitary-thyroid axis. Gary et al. [Gary, K.A., Sevarino, K.A., Yarbrough, G.G., Prange, A.J. Jr., Winokur, A. (2003). The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 305(2):410-416.] and Yarbrough et al. [Yarbrough, G.G., Kamath, J., Winokur, A., Prange, A.J. Jr. (2007). Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses 69(6):1249-1256.] provided a functional framework, predicated on its global homeostatic influences, to conceptualize the numerous interactions of TRH with the central nervous system (CNS) and endocrine system. Herein, we profer a similar analysis to interactions of TRH with the immune system. Autocrine/paracrine cellular signaling motifs of TRH and TRH receptors are expressed in several tissues and organs of the immune system. Consistent with this functional distribution, in vitro and in vivo evidence suggests a critical role for TRH during the developmental stages of the immune system as well as its numerous interactions with the fully developed immune system. Considerable evidence supports a pivotal role for TRH in the pathophysiology of the inflammatory process with specific relevance to the "cytokine-induced sickness behavior" paradigm. These findings, combined with a number of documented clinical actions of TRH strongly support a potential utility of TRH-based therapeutics in select inflammatory disorders. Similar to its global role in behavioral and energy homeostasis a homeostatic role for TRH in its interactions with the immune system is consonant with the large body of available data. Recent advances in the field of immunology provide a significant opportunity for investigation of the TRH-immune system homeostatic hypothesis. Moreover, this hypothesis may provide a foundation for the development of TRH-based therapeutics for certain medical and psychiatric disorders involving immune dysfunction.

Citing Articles

Host-virus interactions during infection with a wild-type ILTV strain or a glycoprotein G deletion mutant ILTV vaccine strain in an system.

Gopakumar G, Coppo M, Diaz-Mendez A, Hartley C, Devlin J Microbiol Spectr. 2025; 13(2):e0118324.

PMID: 39804092 PMC: 11792554. DOI: 10.1128/spectrum.01183-24.


Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19.

de Lima I, Silva A, Brites C, Angelo da Silva Miyaguti N, Raposo Passos Mansoldo F, Vaz Nunes S Int J Mol Sci. 2024; 25(22).

PMID: 39595969 PMC: 11593410. DOI: 10.3390/ijms252211899.


Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration.

Cho J, Lee J, Kim H, Kim J, Park K, Choi S J Mov Disord. 2024; 18(1):35-44.

PMID: 39428104 PMC: 11824505. DOI: 10.14802/jmd.24127.


Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents.

Kagaya M, Uesawa Y Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204191 PMC: 11358984. DOI: 10.3390/ph17081086.


The impact of pre-existing thyroid diseases on susceptibility to respiratory infections or self-reported sickness during the SARS-CoV-2 pandemic.

Rops M, Moorlag S, van Deuren R, Jaeger M, Joosten L, Medici M Arch Endocrinol Metab. 2022; 66(4):472-480.

PMID: 35657122 PMC: 10697642. DOI: 10.20945/2359-3997000000436.